PL1660484T3 - Metyloindole i metylopirolopirydyny jako agoniści receptora adrenergicznego α-1 - Google Patents
Metyloindole i metylopirolopirydyny jako agoniści receptora adrenergicznego α-1Info
- Publication number
- PL1660484T3 PL1660484T3 PL04739120T PL04739120T PL1660484T3 PL 1660484 T3 PL1660484 T3 PL 1660484T3 PL 04739120 T PL04739120 T PL 04739120T PL 04739120 T PL04739120 T PL 04739120T PL 1660484 T3 PL1660484 T3 PL 1660484T3
- Authority
- PL
- Poland
- Prior art keywords
- sup
- methyl
- alpha
- pyrrolopyridines
- adrenergic agonists
- Prior art date
Links
- BHNHHSOHWZKFOX-UHFFFAOYSA-N 2-methyl-1H-indole Chemical class C1=CC=C2NC(C)=CC2=C1 BHNHHSOHWZKFOX-UHFFFAOYSA-N 0.000 title 1
- FTDBLXOLABKXNQ-UHFFFAOYSA-N 2-methyl-1h-pyrrolo[3,2-b]pyridine Chemical class C1=CC=C2NC(C)=CC2=N1 FTDBLXOLABKXNQ-UHFFFAOYSA-N 0.000 title 1
- 239000000048 adrenergic agonist Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000018 receptor agonist Substances 0.000 abstract 2
- 229940044601 receptor agonist Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Gynecology & Obstetrics (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46925503P | 2003-05-09 | 2003-05-09 | |
| EP04739120A EP1660484B1 (en) | 2003-05-09 | 2004-04-30 | Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists |
| PCT/EP2004/004609 WO2004099189A1 (en) | 2003-05-09 | 2004-04-30 | Methyl indoles and methyl pyrrolopyridines as alph-1 adrenergic agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1660484T3 true PL1660484T3 (pl) | 2009-02-27 |
Family
ID=33435226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04739120T PL1660484T3 (pl) | 2003-05-09 | 2004-04-30 | Metyloindole i metylopirolopirydyny jako agoniści receptora adrenergicznego α-1 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6979696B2 (pl) |
| EP (1) | EP1660484B1 (pl) |
| JP (1) | JP4454622B2 (pl) |
| KR (1) | KR100751163B1 (pl) |
| CN (1) | CN100378097C (pl) |
| AT (1) | ATE406363T1 (pl) |
| AU (1) | AU2004235923B2 (pl) |
| BR (1) | BRPI0410237A (pl) |
| CA (1) | CA2523253C (pl) |
| DE (1) | DE602004016177D1 (pl) |
| ES (1) | ES2313019T3 (pl) |
| MX (1) | MXPA05011841A (pl) |
| PL (1) | PL1660484T3 (pl) |
| RU (1) | RU2313524C2 (pl) |
| WO (1) | WO2004099189A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05004929A (es) * | 2002-11-07 | 2005-08-18 | Akzo Nobel Nv | Indoles utiles en el tratamiento de enfermedades relacionadas a receptor de androgeno. |
| TW200602317A (en) * | 2004-04-23 | 2006-01-16 | Akzo Nobel Nv | Novel androgens |
| BRPI0616459A2 (pt) * | 2005-09-29 | 2011-06-21 | Wyeth Corp | compostos das fórmulas i, ii, e iii; processos para o tratamento ou para a prevenção de: um estado de saúde com melhora devido à recaptação de monoamina; pelo menos um sintoma vasomotor; pelo menos um distúrbio depressivo; pelo menos uma disfunção sexual; para a prevenção de dor; de distúrbio gastrointestinal ou genitourinário; de sìndrome de fadiga crÈnica; de sìndrome de fibromialgia; de esquizofrenia; e uso de um composto |
| DE602006009138D1 (de) * | 2005-11-30 | 2009-10-22 | Hoffmann La Roche | 3-amino-2-arylpropylazaindole und anwendungen davon |
| US9133168B2 (en) | 2010-12-28 | 2015-09-15 | Sanofi | Pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors |
| CN102702196B (zh) * | 2012-06-13 | 2015-01-14 | 南京药石药物研发有限公司 | 3-甲基-7-氮杂吲哚的合成方法 |
| KR102129842B1 (ko) * | 2013-10-02 | 2020-07-06 | 주식회사 대웅제약 | 술포닐인돌 유도체 및 이의 제조방법 |
| US10358438B2 (en) * | 2014-07-21 | 2019-07-23 | Arizona Board Of Regents On Behalf Of The University Of Arizona | [3+2] annulation to produce 5-membered heterocyclic compounds |
| CN119998277A (zh) * | 2022-10-14 | 2025-05-13 | 株式会社三和化学研究所 | 咪唑衍生物 |
| WO2024254218A2 (en) * | 2023-06-05 | 2024-12-12 | The Board Of Regents Of The University Of Texas System | Non-peptide small molecule fgf14:nav1.6 channel complex protein-protein interaction modulators |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3370063A (en) | 1964-10-05 | 1968-02-20 | Mcneilab Inc | Substituted dimethoxy indoles and method of making the same |
| US3586695A (en) * | 1968-01-26 | 1971-06-22 | Dow Chemical Co | Substituted imidazolinyl indoles |
| GB9011335D0 (en) | 1990-05-21 | 1990-07-11 | Fujisawa Pharmaceutical Co | Indolebutyric acid derivatives and process for preparation thereof |
| BR9406823A (pt) | 1993-06-14 | 1996-03-26 | Pfizer | Aminas secundárias e agentes anti-diabéticos e antiobesidade |
| JPH0887346A (ja) * | 1994-09-14 | 1996-04-02 | Chino Kogyo:Kk | パソコン等デスク上を活用する為の卓上台座器具 |
| WO1998021184A1 (en) | 1996-11-14 | 1998-05-22 | Pfizer Inc. | Process for substituted pyridines |
| SG72827A1 (en) * | 1997-06-23 | 2000-05-23 | Hoffmann La Roche | Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives |
| GB9910110D0 (en) * | 1999-04-30 | 1999-06-30 | Glaxo Group Ltd | Chemical compounds |
| WO2001070687A1 (de) | 2000-03-23 | 2001-09-27 | Bayer Aktiengesellschaft | Indole zur behandlung von krankheiten die mit schilddrüsenhormonen behandeln werden können |
| DE10106214A1 (de) * | 2001-02-10 | 2002-08-14 | Boehringer Ingelheim Pharma | Neue Alkyl-phenylimino-imidazolidin-Derivate zur Behandlung der Harninkontinenz |
| RU2337909C2 (ru) * | 2002-02-01 | 2008-11-10 | Ф.Хоффманн-Ля Рош Аг | Замещенные индолы и фармацевтическая композиция, обладающая агонистической активностью в отношении альфа-1a/l адренорецептора |
-
2004
- 2004-04-30 RU RU2005138143/04A patent/RU2313524C2/ru not_active IP Right Cessation
- 2004-04-30 AT AT04739120T patent/ATE406363T1/de active
- 2004-04-30 EP EP04739120A patent/EP1660484B1/en not_active Expired - Lifetime
- 2004-04-30 DE DE602004016177T patent/DE602004016177D1/de not_active Expired - Lifetime
- 2004-04-30 AU AU2004235923A patent/AU2004235923B2/en not_active Ceased
- 2004-04-30 WO PCT/EP2004/004609 patent/WO2004099189A1/en not_active Ceased
- 2004-04-30 CN CNB2004800122944A patent/CN100378097C/zh not_active Expired - Fee Related
- 2004-04-30 ES ES04739120T patent/ES2313019T3/es not_active Expired - Lifetime
- 2004-04-30 PL PL04739120T patent/PL1660484T3/pl unknown
- 2004-04-30 BR BRPI0410237-1A patent/BRPI0410237A/pt not_active IP Right Cessation
- 2004-04-30 CA CA2523253A patent/CA2523253C/en not_active Expired - Fee Related
- 2004-04-30 KR KR1020057021188A patent/KR100751163B1/ko not_active Expired - Fee Related
- 2004-04-30 MX MXPA05011841A patent/MXPA05011841A/es active IP Right Grant
- 2004-04-30 JP JP2006505343A patent/JP4454622B2/ja not_active Expired - Fee Related
- 2004-05-07 US US10/841,288 patent/US6979696B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1784397A (zh) | 2006-06-07 |
| JP2006525970A (ja) | 2006-11-16 |
| MXPA05011841A (es) | 2006-01-26 |
| RU2313524C2 (ru) | 2007-12-27 |
| RU2005138143A (ru) | 2006-08-10 |
| JP4454622B2 (ja) | 2010-04-21 |
| EP1660484B1 (en) | 2008-08-27 |
| US20040224973A1 (en) | 2004-11-11 |
| AU2004235923A1 (en) | 2004-11-18 |
| AU2004235923B2 (en) | 2008-01-24 |
| KR100751163B1 (ko) | 2007-08-22 |
| EP1660484A1 (en) | 2006-05-31 |
| DE602004016177D1 (de) | 2008-10-09 |
| CA2523253A1 (en) | 2004-11-18 |
| KR20060015590A (ko) | 2006-02-17 |
| WO2004099189A1 (en) | 2004-11-18 |
| ES2313019T3 (es) | 2009-03-01 |
| ATE406363T1 (de) | 2008-09-15 |
| CA2523253C (en) | 2010-06-22 |
| US6979696B2 (en) | 2005-12-27 |
| CN100378097C (zh) | 2008-04-02 |
| BRPI0410237A (pt) | 2006-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL361361A1 (pl) | Podstawione 1-aminoalkilolaktamy i ich zastosowanie jako antagonistów receptora muskarynowego | |
| PL361282A1 (pl) | Podstawione 1-aminoalkilo-laktamy i ich zastosowanie jako antagonistów receptora muskarynowego | |
| MXPA04007414A (es) | Indoles sustituidos como agonistas alfa-1. | |
| MXPA04000456A (es) | Analogos de prostaglandina como agonistas del receptor ep4. | |
| BG108420A (en) | New indole derivatives with 5-ht6 receptor affinity | |
| MXPA03011638A (es) | Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6. | |
| MX2009006018A (es) | Derivados de quinuclidinol como antagonistas de receptores muscarinicos. | |
| MXPA05011710A (es) | Derivados de pirimidina con actividad de crf. | |
| TW200613243A (en) | Novel compounds | |
| DE60230424D1 (en) | Arylsulfonyl-derivate mit 5-ht 6-rezeptor-affinität | |
| CA2511255A1 (en) | 2-piperidone derivatives as prostaglandin agonists | |
| MXPA05010824A (es) | Compuestos biciclicos como antagonistas del receptor nr2b. | |
| MY133445A (en) | 2-arylethyl-(piperidin-4-ylmethyl)amine derivetives | |
| PL374019A1 (pl) | Pochodne benzoksazyny jako modulatory 5-HT6 i ichzastosowanie | |
| MXPA04005076A (es) | Derivados de 4-piperidinil alquilamina como antagonistas del receptor muscarinico. | |
| PL1660484T3 (pl) | Metyloindole i metylopirolopirydyny jako agoniści receptora adrenergicznego α-1 | |
| MXPA04005313A (es) | Derivados de aminotetralin como antagonistas del receptor muscarinico. | |
| MXPA04005426A (es) | Derivados de pirazol de anillos fuisionados. | |
| UA95223C2 (ru) | Производные пиридопиримидина, их получение, их применение в терапии | |
| CA2292921A1 (en) | Aryl carboxylic acid and tetrazole derivatives | |
| MXPA05011476A (es) | Imidazolin-2-il-aminofenil-amidas como antagonistas de prostaglandina i2. | |
| NO20060191L (no) | 1-(alkylaminoalkyl-pyrolidin-/piperidinyl)2,2-difenylacetamidderivater som muskarinreceptoragonister | |
| TNSN04105A1 (en) | Imidazoquinoline derivatives | |
| SE0301371D0 (sv) | New Compounds | |
| AU2001258489A1 (en) | Novel vitronectin receptor antagonists |